Get the Stockscreener App
9.19
11.72%
-1.22
Coeptis Therapeutics Holdings Inc stock is traded at $9.19, with a volume of 96,745.
It is down -11.72% in the last 24 hours and up +19.35% over the past month.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
See More
Previous Close:
$10.41
Open:
$9.92
24h Volume:
96,745
Relative Volume:
1.64
Market Cap:
$32.26M
Revenue:
-
Net Income/Loss:
$-11.62M
P/E Ratio:
-1.6411
EPS:
-5.6
Net Cash Flow:
$-6.91M
1W Performance:
-4.87%
1M Performance:
+19.35%
6M Performance:
+134.44%
1Y Performance:
+59.71%
1-Day Range:
$9.19
$10.41
1-Week Range:
$9.19
$10.41
52-Week Range:
$2.31
$13.70
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
Name
Coeptis Therapeutics Holdings Inc
Sector
Industry
Phone
724-934-6467
Address
105 BRADFORD ROAD, SUITE 420, WEXFORD
Compare COEP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COEP
COEPTIS THERAPEUTICS INC
|
6.99 | 2.70M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
9.98 | 214.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.99 | 123.68M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1601 | 354.54M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
0.91 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
39.57 | 0 | 0 | 0 | 0 | 0.00 |
Coeptis Therapeutics Holdings Inc Stock (COEP) Latest News
(COEP) Technical Pivots with Risk Controls - news.stocktradersdaily.com
When the Price of (COEP) Talks, People Listen - news.stocktradersdaily.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders - Finansavisen
Deal Watch: Lilly Looks To Creyon For Oligonucleotides - insights.citeline.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSESKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Banco - Morningstar
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders - TradingView
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (NasdaqKRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancor - TradingView
Coeptis Therapeutics Announces Reverse Stock Split - GuruFocus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders - Morningstar
Dogecoin (DOGE) Closing To This Number Could Propel It To Another All-Time High - blockzeit.com
Financial Review: Coeptis Therapeutics (NASDAQ:COEP) vs. Immunocore (NASDAQ:IMCR) - Defense World
The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc.COEP - marketscreener.com
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc.COEP - PR Newswire
Here's what to know about the Coeptis-Z-Squared mergerPittsburgh Business Times - The Business Journals
Coeptis Therapeutics Holdings Inc’s Banking’s 100-Day Moving Average at 8.75: Will the Stock Break Through? - investchronicle.com
Biopharma Firm Merges With Z Squared to Form Largest Publicly-Listed Dogecoin Miner - Bitcoin.com News
Coeptis Therapeutics, Z Squared announce merger agreement - MSN
Coeptis Therapeutics, Z Squared enter merger agreement - TipRanks
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss - Benzinga
COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders - Business Wire
Coeptis Therapeutics Subsidiary to Merge With Dogecoin Mining Company - marketscreener.com
Coeptis Therapeutics (COEP) Merges with Z Squared, Shifts to Dig - GuruFocus
Coeptis Therapeutics (COEP) to Merge with Z Squared, Enter Digital Asset Mining | COEP Stock News - GuruFocus
Coeptis Therapeutics and Z Squared to Merge - citybiz
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement - The Manila Times
Coeptis Therapeutics Holdings, Inc. Enters Definitive Merger Agreement with Z Squared Inc. to Pursue Dogecoin Mining Venture - Nasdaq
Massive Crypto Pivot: Biotech Firm Acquires 9,000 Dogecoin Miners in Industry-Shaking Merger - Stock Titan
Bear of the Day: Freshpet (FRPT) - The Globe and Mail
Trend Tracker for (COEP) - news.stocktradersdaily.com
COEPTIS announces strategic tech hub in India By Investing.com - Investing.com Canada
COEPTIS announces strategic tech hub in India - Investing.com India
Coeptis Therapeutics announces establishment of new technology hub in India - TipRanks
COEPTIS, Inc. Announces New Co-Working Technology Hub in India in Partnership with NexGenAI Solutions Group and Ishvara Tech Consulting LLP - Nasdaq
COEPTIS Expands Global AI Footprint: $2.3M New Contracts Plus Advanced Tech Hub Launch in India - Stock Titan
Public market insider buying at VerticalScope Holdings (FORA) - The Globe and Mail
(COEP) On The My Stocks Page - news.stocktradersdaily.com
Coeptis Therapeutics (NASDAQ:COEP) Trading Down 0.8% – What’s Next? - Defense World
Market Analysis: Monday March 31, 2025 - The Globe and Mail
Coeptis Therapeutics Holdings Inc. (COEP) reports earnings - Quartz
Coeptis Therapeutics announces executive departure By Investing.com - Investing.com Canada
Coeptis Therapeutics announces executive departure - Investing.com India
How the (COEP) price action is used to our Advantage - news.stocktradersdaily.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Long Term Trading Analysis for (COEP) - Stock Traders Daily
Coeptis forms subsidiary to advance cancer cell therapy By Investing.com - Investing.com Australia
Coeptis Therapeutics Secures Worldwide Rights To GEAR Cell Therapy Platform - Nasdaq
Coeptis Therapeutics Secures Worldwide Development & Commercialization Rights To Next-Generation Gear Cell Therapy Platform - Marketscreener.com
Coeptis forms subsidiary to advance cancer cell therapy - Investing.com India
Coeptis Therapeutics secures worldwide development rights to GEAR Platform - TipRanks
COEPTIS, Inc. Establishes GEAR Therapeutics to Advance Innovative Cancer Cell Therapy into First-in-Human Studies - Nasdaq
Coeptis Therapeutics Holdings Inc Stock (COEP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):